Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vile

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Gene Therapy|July 5, 2001
A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory componentL Emiliusen, M Gough, A Bateman, et al.
Gene Therapy|November 25, 2011
GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distributionS Guedan, D Grases, J J Rojas, et al.
Gene Therapy|September 2, 2005
Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell primingF Errington, J Jones, A Merrick, et al.
Gene Therapy|September 1, 1999
Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccineJ Kayaga, B E Souberbielle, N Sheikh, et al.
British Journal of Cancer|April 7, 2005
Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell primingA Merrick, F Errington, K Milward, et al.
Gene Therapy|October 29, 2004
Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transferI V Scholz, N Cengic, C H Baker, et al.
Gene Therapy|October 26, 2016
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapyE Ilett, T Kottke, J Thompson, et al.
Neurosurgery|January 7, 2022
Blood Biomarkers and Structural Imaging Correlations Post-Traumatic Brain Injury: A Systematic ReviewDaniel P Whitehouse, Alexander R Vile, Krishma Adatia, et al.
International Journal of Cancer|August 29, 2013
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascitesV A Jennings, E J Ilett, K J Scott, et al.
Gene Therapy|April 11, 2008
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanomaF Errington, C L White, K R Twigger, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Gene Therapy|July 5, 2001
A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory componentL Emiliusen, M Gough, A Bateman, et al.
Gene Therapy|November 25, 2011
GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distributionS Guedan, D Grases, J J Rojas, et al.
Gene Therapy|September 2, 2005
Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell primingF Errington, J Jones, A Merrick, et al.
Gene Therapy|September 1, 1999
Anti-tumour activity against B16-F10 melanoma with a GM-CSF secreting allogeneic tumour cell vaccineJ Kayaga, B E Souberbielle, N Sheikh, et al.
British Journal of Cancer|April 7, 2005
Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell primingA Merrick, F Errington, K Milward, et al.
Gene Therapy|October 29, 2004
Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transferI V Scholz, N Cengic, C H Baker, et al.
Gene Therapy|October 26, 2016
Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapyE Ilett, T Kottke, J Thompson, et al.
Neurosurgery|January 7, 2022
Blood Biomarkers and Structural Imaging Correlations Post-Traumatic Brain Injury: A Systematic ReviewDaniel P Whitehouse, Alexander R Vile, Krishma Adatia, et al.
International Journal of Cancer|August 29, 2013
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascitesV A Jennings, E J Ilett, K J Scott, et al.
Gene Therapy|April 11, 2008
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanomaF Errington, C L White, K R Twigger, et al.
Pageof 5